Event Details

Date: October 21, 2025

Location: New York Athletic Club, 180 Central Park S, New York, NY 10019

Event Website: https://avbcc.org/cris

About the Event

Cizzle Bio is proud to announce our attendance in the inaugural Global Cancer Research and Innovation Symposium (GCRIS), hosted by the Association for Value-Based Cancer Care (AVBCC). This highly anticipated one-day event brings together pioneering researchers, biotech innovators, pharmaceutical leaders, and investors with a shared mission: accelerating innovation in cancer research.

Held the day before the 15th Annual AVBCC Summit, GCRIS serves as a powerful platform to showcase cutting-edge developments in oncology and hematology. Cizzle Bio is attending the Global Cancer Research and Innovation Symposium to connect with leaders across oncology research, biotech, and investment. We look forward to meaningful conversations around our biomarker blood tests—CIZ1B for early-stage lung cancer and DEX-G2 for gastric cancer—and to learning from others advancing innovation in early cancer detection and precision diagnostics.

Why We’re Attending

Cizzle Bio is committed to transforming early cancer detection through biomarker innovation. GCRIS offers an ideal setting to:

• Connect with leading experts and legacy researchers.

• Share our clinical progress and upcoming milestones.

• Explore partnerships with pharmaceutical strategics and funding institutions.

• Stay informed on the latest trends in immuno-oncology and translational research.

About the Symposium

GCRIS will feature:

• Keynotes from top cancer research leaders, including Dr. Andrea Cercek (Memorial Sloan Kettering), Dr. Steven Rosen (City of Hope), and Nancy Daly (CEO, Conquer Cancer).

• Pre-screened investigator panels highlighting emerging biotech labs.

• Pitch opportunities for startups to connect with industry decision-makers.

We look forward to contributing to this dynamic and mission-driven event that aligns with Cizzle Bio’s commitment to innovation, access, and improving patient outcomes through early detection.